Skip to main content

General Departmental Management

Schedules

TAFS: 075-0120 /X - General Departmental Management

Iterations:
Adjustment authority: Yes
Reporting categories: No
Line #SplitDescriptionIteration 1
Previously Approved Amount
Iteration 2
Current OMB Action Amount
Footnotes
1000DADiscretionary Actual - Unob Bal: Brought forward, Oct 1Line added+$1,564,428
$1,564,428
1000MEMandatory Expected - Unob Bal: Brought forward, Oct 1$14,449,212-$14,449,212
$0
1000MAMandatory Actual - Unob Bal: Brought forward, Oct 1Line added+$24,946,743
$24,946,743
1000DEDiscretionary Expected - Unob Bal: Brought forward, Oct 1$1,300,000-$1,300,000
$0
1021Unob Bal: Recov of prior year unpaid obligations$1,500,000-$1,461,523
$38,477
1033Unob Bal: Recov of prior year paid obligations$100,000+$99,188
$199,188
1700BA: Disc: Spending auth: CollectedLine added+$1,555,942
$1,555,942
1701BA: Disc: Spending auth: Chng uncoll pymts Fed srcLine added-$805,942
-$805,942
1740BA: Disc: Spending auth:Antic colls, reimbs, other$85,000,000-$750,000
$84,250,000
1840BA: Mand: Spending auth:Antic colls, reimbs, other$4,750,000+$5,027,000
$9,777,000
1920Total budgetary resources avail (disc. and mand.)$107,099,212+$14,426,624
$121,525,836
6001Category A -- 1st quarter$93,770,038 $93,770,038
6002Category A -- 2nd quarterLine added+$7,675,496
$7,675,496
6012Category B -- Prevention and Public Health Funds$3,000,000-$2,890,000
$110,000
6013Category B -- Physician-Focused Payment Model Technical Advisory Committee$5,000,000-$81,700
$4,918,300
6015Category B -- Inflation Reduction Act Drug Data$4,000,000 $4,000,000
6170Apportioned in FY 2027$1,329,174+$9,722,828
$11,052,002
6190Total budgetary resources available$107,099,212+$14,426,624
$121,525,836
See footnotes below
Footnotes for line 6190 (Previous):

A1: The total amount apportioned may be increased for additional spending authority from offsetting collections/reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

A2: The funds apportioned are in an amount consistent with what HHS estimates as "necessary" per the HHS approved spend plan to fulfill its statutory authority to support the Physician-Focused Payment Model Technical Advisory Committee under the Medicare Access and CHIP Reauthorization Act of 2015 (P.L.114-10). This apportionment is with the understanding that, for FY 2026, HHS has agreed to forgo any transfer of funds from the Trust Fund on grounds that the transfer is not "necessary under 42 USC section 1395ee(c)(1)(F)(ii) due to the availability of carryover funds. [Rationale: Footnote specifies the source of funding.]

Footnotes for line 6190 (Current):

A1: The total amount apportioned may be increased for additional spending authority from offsetting collections/reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

A2: The funds apportioned are in an amount consistent with what HHS estimates as "necessary" per the HHS approved spend plan to fulfill its statutory authority to support the Physician-Focused Payment Model Technical Advisory Committee under the Medicare Access and CHIP Reauthorization Act of 2015 (P.L.114-10). This apportionment is with the understanding that, for FY 2026, HHS has agreed to forgo any transfer of funds from the Trust Fund on grounds that the transfer is not "necessary under 42 USC section 1395ee(c)(1)(F)(ii) due to the availability of carryover funds. [Rationale: Footnote specifies the source of funding.]

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
The total amount apportioned may be increased for additional spending authority from offsetting collections/reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]
A2
The funds apportioned are in an amount consistent with what HHS estimates as "necessary" per the HHS approved spend plan to fulfill its statutory authority to support the Physician-Focused Payment Model Technical Advisory Committee under the Medicare Access and CHIP Reauthorization Act of 2015 (P.L.114-10). This apportionment is with the understanding that, for FY 2026, HHS has agreed to forgo any transfer of funds from the Trust Fund on grounds that the transfer is not "necessary under 42 USC section 1395ee(c)(1)(F)(ii) due to the availability of carryover funds. [Rationale: Footnote specifies the source of funding.]

The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.

NumberText
A1
The total amount apportioned may be increased for additional spending authority from offsetting collections/reimbursables received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available without further action by OMB. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]
A2
The funds apportioned are in an amount consistent with what HHS estimates as "necessary" per the HHS approved spend plan to fulfill its statutory authority to support the Physician-Focused Payment Model Technical Advisory Committee under the Medicare Access and CHIP Reauthorization Act of 2015 (P.L.114-10). This apportionment is with the understanding that, for FY 2026, HHS has agreed to forgo any transfer of funds from the Trust Fund on grounds that the transfer is not "necessary under 42 USC section 1395ee(c)(1)(F)(ii) due to the availability of carryover funds. [Rationale: Footnote specifies the source of funding.]

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.